drugset / Trial / NCT00415090

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

NCT00415090

Phase 4 Completed 28 enrolled Hospital de Calella
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the proportion of patients with viral load of HIV-1 \< 50 copies after 48 weeks of follow-up after randomization to change or not to nevirapine.

Timeline

Start
2004-08
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule